Form 8-K - Current report:
SEC Accession No. 0000930413-20-000918
Filing Date
2020-03-27
Accepted
2020-03-27 17:07:44
Documents
19
Period of Report
2020-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c95505_8k-ixbrl.htm   iXBRL 8-K 24575
2 c95505_ex1-1.htm EX-1.1 143268
3 c95505_ex1-2.htm EX-1.2 30223
4 c95505_ex4-2.htm EX-4.2 83191
5 c95505_ex5-1.htm EX-5.1 20891
6 GRAPHIC image_002.jpg GRAPHIC 2438
7 GRAPHIC image_003.jpg GRAPHIC 2743
  Complete submission text file 0000930413-20-000918.txt   534178

Data Files

Seq Description Document Type Size
8 pfe-20200325.xsd EX-101.SCH 3706
9 pfe-20200325_def.xml EX-101.DEF 12995
10 pfe-20200325_lab.xml EX-101.LAB 24964
11 pfe-20200325_pre.xml EX-101.PRE 12983
15 EXTRACTED XBRL INSTANCE DOCUMENT c95505_8k-ixbrl_htm.xml XML 4413
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20752741
SIC: 2834 Pharmaceutical Preparations